Literature DB >> 8699542

Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program.

L Amass1, W K Bickel, J P Crean, S T Higgins, G J Badger.   

Abstract

This study evaluated preferences for various clinic privileges, retail items, and social activities for use in an outpatient opioid dependence treatment program. Fifty-three opioid-dependent patients who received treatment with buprenorphine for at least 30 days rank ordered 11 clinic privileges, 19 retail items, and 8 social activities from the most desirable (a rank of 1) to the least desirable (a rank equal to the number of items in that category). Additional questions determined preference for counseling frequency and dosing levels. The top three mean rankings for clinic privileges were $50 cash for opioid-negative urines (2.8), take-home doses of buprenorphine (3.6), and voucher points for opioid-negative urines (4.7). The top three mean rankings for retail items were restaurant gift certificates (4.1), movie passes (4.9), and videotape movie and player rentals (6.8). The top three mean rankings for social activities were movies (2.4), barbecues (3.8), and hiking trips (4.3). There was no preference reported for increases or decreases in counseling frequency. Seventy-four percent of subjects preferred to increase their buprenorphine dose by an average of 60.84% independent of their present dose. Consistent with previous findings from methadone treatment, cash payments for opioid-negative urines and take-home medication were the highest ranked clinic privileges. These results suggest that various retail items and social activities may also be useful for reinforcing positive treatment outcomes during outpatient opioid treatment.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699542     DOI: 10.1016/0740-5472(95)02060-8

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  13 in total

1.  A tale of two cities: financing two voucher programs for substance abusers through community donations.

Authors:  Leslie Amass; Jonathan Kamien
Journal:  Exp Clin Psychopharmacol       Date:  2004-05       Impact factor: 3.157

2.  Facilitating the adoption of contingency management for the treatment of substance use disorders.

Authors:  John M Roll; Gregory J Madden; Richard Rawson; Nancy M Petry
Journal:  Behav Anal Pract       Date:  2009

3.  Hypothetical intertemporal choice and real economic behavior: delay discounting predicts voucher redemptions during contingency-management procedures.

Authors:  Warren K Bickel; Bryan A Jones; Reid D Landes; Darren R Christensen; Lisa Jackson; Michael Mancino
Journal:  Exp Clin Psychopharmacol       Date:  2010-12       Impact factor: 3.157

4.  The influence of monetary compensation on relapse among addicted participants: empirical vs. anecdotal evidence.

Authors:  Jared P Dempsey; Sudie E Back; Angela E Waldrop; Lisa Jenkins; Kathleen T Brady
Journal:  Am J Addict       Date:  2008 Nov-Dec

5.  Financing a voucher program for cocaine abusers through community donations in Spain.

Authors:  Olaya García-Rodríguez; Roberto Secades-Villa; Stephen T Higgins; José R Fernández-Hermida; José L Carballo
Journal:  J Appl Behav Anal       Date:  2008

6.  Effective Strategies for Maintaining Research Participation in Clinical Trials.

Authors:  Allen Zweben; Lisa M Fucito; Stephanie S O'Malley
Journal:  Drug Inf J       Date:  2009-07

Review 7.  The use of financial incentives in promoting smoking cessation.

Authors:  Stacey C Sigmon; Mollie E Patrick
Journal:  Prev Med       Date:  2012-04-16       Impact factor: 4.018

8.  Contingency management for cocaine treatment: cash vs. vouchers.

Authors:  David S Festinger; Karen L Dugosh; Kimberly C Kirby; Brittany L Seymour
Journal:  J Subst Abuse Treat       Date:  2014-03-06

9.  Interest and preferences for contingency management design among addiction treatment clientele.

Authors:  Bryan Hartzler; Sharon Garrett
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-08       Impact factor: 3.829

10.  Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion.

Authors:  David S Festinger; Douglas B Marlowe; Karen L Dugosh; Jason R Croft; Patricia L Arabia
Journal:  Drug Alcohol Depend       Date:  2008-04-18       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.